Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Prostate Cancer Castration-resistant Prostate Cancer · Breast Cancer · Colo-rectal Cancer · Lung Cancer (Non-Small Cell) · Pancreas Cancer, Duct Cell Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Contact: Principal Investigator (Rauhl Aggarwal, MD)START, Midwest, Grand Rapids, Michigan, United States
START, Astera, East Brunswick, New Jersey, United States
Contact: Principal Investigator (Bruno S Fang, MD)NEXT, Dallas, Irving, Texas, United States
Contact: Study coordinator (Mofopefoluwa Akinwale)START San Antonio, San Antonio, Texas, United States
Contact: Study coordinator (Kyruakos P Papadopoulos, MD) · isabel.jimenez@startresearch.com · 2105935265START, Mountain Region, West Valley City, Utah, United States
Contact: Study coordinator (William B McKean, MD, PhD) · marie.asay@startresearch.com · 801-907-4750NEXT, Virginia, Fairfax, Virginia, United States
Contact: Study coordinator (Maybelle De La Rosa)